Eli Hurvitz, Chairman of the Board of Teva Pharmaceutical Industries, Ltd., Israel Makov, President and CEO, Dan S. Suesskind CFO, and Mr. Shlomo Yanai, designated President and CEO, preside over the Market Open

Wednesday February 21, 2007
at NASDAQ's MarketSite
in New York City.

Teva Pharmaceutical Industries, Ltd.
[TEVA]

Dan S. Suesskind, CFO of Teva Pharmaceutical Industries, Ltd., Shlomo Yanai, designated President and CEO, Israel Makov, President and CEO and Eli Hurvitz, Chairman of the Board Ring The NASDAQ Stock Market Open Bell in celebration of the company's 25 year listing anniversary.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.

Reprints

Click for larger pictures of the NASDAQ MarketSite. Additional Photographs for 02/21/2007 Download Hi-Res Quality Photo of this NASDAQ Market Open - Pictured: Eli Hurvitz, Chairman of the Board of Teva Pharmaceutical Industries, Ltd., Israel Makov, President and CEO, Dan S. Suesskind CFO, and Mr. Shlomo Yanai, designated President and CEO, presides over the opening bell. These photos are Copyright 2007, The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of The Nasdaq Stock Market Inc. © Copyright 2007, The NASDAQ Stock Market, Inc. Reprinted with the permission of The Nasdaq Stock Market, Inc.